|
Lee Meisel is president of Windsor Bay Capital, Inc. and managing member of Orion Capital Group, LLC. He currently serves as a director of Targa Therapeutics Corporation. Dr. Meisel previously was Vice President, Operations and director of CPS Chemical Corporation. While at CPS Chemical, he was a member of the executive management team that sold the company to Allied Colloids in the United Kingdom. At CPS, he was co-inventor of several patented chemical processes that covered numerous patented new compositions of matter. Dr. Meisel has worked as a corporate and securities attorney for the biotechnology industry at Brobeck, Phleger and Harrison in Palo Alto, California and as Chief of the Department of Anesthesia for Kaiser Permanente Medical Center in San Francisco. He received his law degree from Stanford Law School and completed his medical training as a fellow in critical care medicine and a resident in anesthesiology at Harvard Medical School. His Masters of Public Health degree is from the Harvard School of Public Health. | 